Nanalyze November 7, 2020
When you’ve been writing about technology for as long as we have at Nanalyze you start to see patterns emerge. One of the most interesting – and potentially biggest game-changers in the healthcare arena – is the emergence of precision medicine. The approach takes into account individual variability in genes, among other factors, to predict what treatment might be most effective across a range of diseases. Advances in areas such as next-generation sequencing (NGS) mean we can understand things like cancer tumors at the molecular level, leading to specific therapies that target gene-mutated cells while sparing the healthy ones, for example. Precision medicine, at its core, is really about better diagnostics. A startup called Tempus is creating its own whirlwind...
Today's Sponsors
Today's Sponsor